Treace Medical Concepts, Inc.
TMCI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $462,114 | $775,865 | $1,270,814 | $1,009,935 |
| - Cash | $11,350 | $12,982 | $19,473 | $105,833 |
| + Debt | $69,653 | $70,303 | $68,589 | $29,365 |
| Enterprise Value | $520,417 | $833,186 | $1,319,930 | $933,467 |
| Revenue | $209,357 | $187,118 | $141,838 | $94,419 |
| % Growth | 11.9% | 31.9% | 50.2% | – |
| Gross Profit | $168,264 | $151,937 | $114,315 | $77,531 |
| % Margin | 80.4% | 81.2% | 80.6% | 82.1% |
| EBITDA | -$42,068 | -$39,008 | -$36,284 | -$15,807 |
| % Margin | -20.1% | -20.8% | -25.6% | -16.7% |
| Net Income | -$55,743 | -$49,527 | -$42,815 | -$20,552 |
| % Margin | -26.6% | -26.5% | -30.2% | -21.8% |
| EPS Diluted | -0.9 | -0.81 | -0.77 | -0.38 |
| % Growth | -11.1% | -5.2% | -102.6% | – |
| Operating Cash Flow | -$37,167 | -$34,575 | -$30,648 | -$17,193 |
| Capital Expenditures | -$11,593 | -$11,458 | -$14,838 | -$2,705 |
| Free Cash Flow | -$48,760 | -$46,033 | -$45,486 | -$19,898 |